TABLE 3.
Target DNA | No. of copies of DNA per reaction | No. (%) of measurements above the limit of detection for 28 replicates (HIV-1) or 12 replicates (CCR5) | Mean ± SD of exptl valuesb | CV (%) of exptl valuesb |
---|---|---|---|---|
HIV-1 | 106 | 28 (100) | 5.89 ± 0.12 | 2.0 |
105 | 28 (100) | 4.93 ± 0.16 | 3.2 | |
104 | 28 (100) | 3.83 ± 0.16 | 4.0 | |
103 | 28 (100) | 2.97 ± 0.12 | 4.0 | |
102 | 28 (100) | 2.03 ± 0.24 | 11.6 | |
10 | 9 (32.1) | 1.00 ± 0.27 | 27.3 | |
CCR5 | 106 | 12 (100) | 5.92 ± 0.29 | 4.9 |
105 | 12 (100) | 5.03 ± 0.21 | 4.2 | |
104 | 12 (100) | 3,94 ± 0.12 | 2.9 | |
103 | 12 (100) | 3.06 ± 0.20 | 6.6 | |
102 | 12 (100) | 2.05 ± 0.19 | 9.3 | |
10 | 12 (100) | 1.05 ± 0.29 | 27.6 |
Each reaction was performed in a multiplex setting, with each reaction mix including, in addition to the standards, 103 copies of HIV-1 DNA and 5 × 105 CCR5 copies for CCR5 and HIV-1 DNA quantifications, respectively, in a final volume of 25 μl.
Log10-transformed data.